False ‘aspirin resistance’ diagnoses lead to costly prescriptions: study

(Bloomberg) — There’s no such thing as aspirin resistance, according to a study that suggests a false diagnosis may be unnecessarily raising the number of people given costlier prescription drugs with more side effects to lower their risk of heart attack and stroke.

Get access to this article and thousands more...

All Employee Benefit News articles are archived after 7 days. REGISTER NOW for unlimited access to all recently archived articles, as well as thousands of searchable stories. Registered Members also gain access to exclusive industry white paper downloads, web seminars, podcasts, e-books, blog discussions, the iPad App, and conference discounts. Qualified members may also choose to receive our free monthly magazine for benefits professionals and any of our e-newsletters covering the latest breaking news, opinions from industry leaders, developing trends and product updates.

Already Registered?

Already a subscriber? Log in here